Laurel Wealth Advisors LLC Novartis Ag Transaction History
Laurel Wealth Advisors LLC
- $6.97 Billion
- Q2 2025
A detailed history of Laurel Wealth Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Laurel Wealth Advisors LLC holds 117,864 shares of NVS stock, worth $14.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
117,864
Previous 974
12001.03%
Holding current value
$14.6 Million
Previous $108,000
801.85%
% of portfolio
0.01%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding NVS
# of Institutions
1,582Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.32 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.29 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.12 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$936 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$882 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $266B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...